(Q56774608)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19893593%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

title

Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19893593%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19893593%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

François-Loic Cosset

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19893593%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Jean-Luc Coll

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19893593%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

E-H Lin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19893593%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

C Salon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19893593%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

E Brambilla

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19893593%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

J Szecsi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19893593%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

publication date

6 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19893593%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19893593%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19893593%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19893593%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

256-265

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19893593%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/cgt.2009.74

11 February 2020

exact match

0 references

cites work

A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Syncytia induction enhances the oncolytic potential of vesicular stomatitis virus in virotherapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Combination of a fusogenic glycoprotein, prodrug activation, and oncolytic herpes simplex virus for enhanced local tumor control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Enhanced killing of pancreatic cancer cells by expression of fusogenic membrane glycoproteins in combination with chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Synthesis, assembly, and processing of the Env ERVWE1/syncytin human endogenous retroviral envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

The RD114/simian type D retrovirus receptor is a neutral amino acid transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Intercellular trafficking and protein delivery by a herpesvirus structural protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Direct evidence for the absence of intercellular trafficking of VP22 fused to GFP or to the herpes simplex virus thymidine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Intercellular trafficking of VP22-GFP fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Intercellular delivery of functional p53 by the herpesvirus protein VP22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Intercellular trafficking of VP22-GFP fusion proteins is not observed in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Evidence for intercellular trafficking of VP22 in living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Respiratory syncytial virus decreases p53 protein to prolong survival of airway epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Novel cell death program leads to neutrophil extracellular traps

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

7 January 2021

Antitumor activity of bax and p53 naked gene transfer in lung cancer: in vitro and in vivo analysis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

7 January 2021

Poor intercellular transport and absence of enhanced antiproliferative activity after non-viral gene transfer of VP22-P53 or P53-VP22 fusions into p53 null cell lines in vitro or in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

7 January 2021

Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.74

7 January 2021

Identifiers

DOI

10.1038/CGT.2009.74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19893593%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

11 February 2020

0 references

1 reference